Skip to main content
. 2018 Oct 31;21(1):87–91. doi: 10.1177/1751143718809678

Table 2.

Diagnostic criteria adapted from the HLH-2004 trial.

Molecular identification of an HLH-associated gene mutation (e.g. PRF1, UNC13D, STX11, STXBP2, Rab27A, SH2D1A, BIRC4, LYST, ITK, SLC7A7, XMEN, and HPS)
OR
Five of the following eight findings:
1. Fever ≥ 38.5℃
2. Splenomegaly
3. Peripheral blood cytopenia
4. Hypertriglyceridemia (fasting triglycerides >265 mg/dL) and/or hypofibrinogenaemia (fibrinogen < 150 mg/dL)
5. Haemophagocytosis in bone marrow, spleen, lymph node or liver
6. Low or absent NK cell activity
7. Ferritin > 500 ng/mL
8. Elevated soluble CD25 (soluble IL-2 receptor alpha) two standard deviations above age-adjusted laboratory-specific norms

Note: Adapted from Jordan et al.1